DZ Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,122
| Closed | -$1.67M | – | 1054 |
|
|
2024
Q2 | $1.67M | Sell |
12,122
-16,344
| -57% | -$2.25M | ﹤0.01% | 583 |
|
|
2024
Q1 | $3.93M | Buy |
28,466
+9,955
| +54% | +$1.37M | ﹤0.01% | 478 |
|
|
2023
Q4 | $2.44M | Sell |
18,511
-1,969
| -10% | -$259K | ﹤0.01% | 528 |
|
|
2023
Q3 | $2.3M | Sell |
20,480
-19,821
| -49% | -$2.23M | ﹤0.01% | 524 |
|
|
2023
Q2 | $3.8M | Sell |
40,301
-9,575
| -19% | -$903K | 0.01% | 484 |
|
|
2023
Q1 | $5.05M | Sell |
49,876
-2,271
| -4% | -$230K | 0.01% | 437 |
|
|
2022
Q4 | $6.23M | Buy |
52,147
+16,943
| +48% | +$2.02M | 0.01% | 402 |
|
|
2022
Q3 | $3.74M | Buy |
35,204
+23,516
| +201% | +$2.5M | 0.01% | 457 |
|
|
2022
Q2 | $1.14M | Hold |
11,688
| – | – | ﹤0.01% | 680 |
|
|
2022
Q1 | $1.1M | Sell |
11,688
-5,319
| -31% | -$498K | ﹤0.01% | 699 |
|
|
2021
Q4 | $1.44M | Buy |
17,007
+12,304
| +262% | +$1.04M | ﹤0.01% | 664 |
|
|
2021
Q3 | $451K | Buy |
+4,703
| New | +$451K | ﹤0.01% | 782 |
|
|
2018
Q2 | – | Sell |
-60,700
| Closed | -$5.03M | – | 987 |
|
|
2018
Q1 | $5.03M | Buy |
+60,700
| New | +$5.03M | 0.02% | 394 |
|